Cyberattacks Hit Health Sector, Feds Criticizedby Lilu Anderson 29.09.2024Health industry faces ongoing cyberattacks; federal response criticized for lack of funding and focus.
Iontronic Tech Promises Hope in Slowing Malignant Brain Tumorsby Lilu Anderson 20.06.2024"Iontronic tech shows promise in slowing malignant brain tumor growth by continuously delivering low-dose drugs, bypassing the blood-brain barrier."
Biotechnology Diversity: Driving Innovation #DiversityinBiotechnologyby Lilu Anderson 19.02.2024Diversity in biotechnology and venture capital is crucial for driving innovation and breakthroughs in healthcare, according to Dr. Stanley Lewis. ...
Revolutionizing Success: Diversity Boosts Biotech VC Fundingby Lilu Anderson 19.02.2024Efforts to diversify biotech venture capital funding could lead to innovation, breakthroughs in healthcare, and improved outcomes for minorities.
Merrimack Pharmaceuticals Closure: Impact on Shareholdersby Mark Eisenberg 14.02.2024Merrimack Pharmaceuticals is set to dissolve after receiving a $225 million payment for FDA approval. Shareholders will receive a dividend ...
G1 Therapeutics Phase 3 Trial Update: Market Responseby Mark Eisenberg 13.02.2024Shares of G1 Therapeutics plunged 46% after disappointing results from their Phase 3 trilaciclib combination trial for triple-negative breast cancer. ...